Benzodiazepine receptor photoaffinity labeling: correlation of function with binding.
Exhaustive photoaffinity coupling of flunitrazepam to living spinal cord neurons reduced the capacity of benzodiazepines to potentiate the electrophysiologically measured GABA response. In qualitative agreement with reversible binding data the dose-response curve for enhancement of the GABA response by benzodiazepines was shifted to the right, indicating that the remaining reversible benzodiazepine binding sites have lower affinity for benzodiazepines. Photoaffinity labeling did not reduce inhibition of the GABA response by beta-carbolines and there was only a small decrease in beta-carboline binding. In both control and photoaffinity-labeled cultures, the inhibitory effect of beta-carbolines on the GABA response was reversed in the presence of excess benzodiazepine. The results indicate that the effects of photoaffinity labeling are confined to the BZD recognition site, and that coupling between benzodiazepine receptors and GABA receptors remains intact.
Gibbs
T T
TT
Chan
C Y
CY
Czajkowski
C M
CM
Farb
D H
DH
D000345:Affinity Labels; D000818:Animals; D001667:Binding, Competitive; D001921:Brain / Q000378:metabolism; D002243:Carbolines / Q000494:pharmacology; D002642:Chick Embryo; D004594:Electrophysiology; D005445:Flunitrazepam / Q000378:metabolism; D008027:Light; D008566:Membranes / Q000378:metabolism; D009474:Neurons / Q000378:metabolism; D011963:Receptors, GABA-A / Q000378:metabolism*; D013116:Spinal Cord / Q000378:metabolism
D000345:Affinity Labels; D002243:Carbolines; D011963:Receptors, GABA-A; D005445:Flunitrazepam; C036150:beta-carboline-3-carboxylic acid methyl ester